John Hart to Rats, Sprague-Dawley
This is a "connection" page, showing publications John Hart has written about Rats, Sprague-Dawley.
Connection Strength
0.051
-
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human. Int J Neuropsychopharmacol. 2014 Oct 31; 18(2).
Score: 0.026
-
Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344. J Pharmacol Exp Ther. 2006 Feb; 316(2):905-13.
Score: 0.014
-
Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res. 2003 Jul 01; 63(13):3517-23.
Score: 0.012